Cargando…

Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series

Two patients with normal renal function, yet each showed unexpected, supra‐ and subtherapeutic linezolid plasma concentrations resulting in toxicity and ineffective therapy, respectively. TDM helps to early identify and correct such excursions.

Detalles Bibliográficos
Autores principales:	Alghamdi, Wael A., Al‐Shaer, Mohammad H., Klinker, Kenneth P., Peloquin, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364108/ https://www.ncbi.nlm.nih.gov/pubmed/32695341 http://dx.doi.org/10.1002/ccr3.2835

Ejemplares similares

1825. Optimizing β-lactam Therapy in Surgical Intensive Care Unit Patients Using Therapeutic Drug Monitoring
por: Al-Shaer, Mohammad H, et al.
Publicado: (2019)

Therapeutic drug monitoring: linezolid too?
por: Richards, Guy A, et al.
Publicado: (2014)

1101. Implementing a Beta-Lactam Therapeutic Drug Monitoring Program: Experience from a Large Academic Medical Center
por: Veena, Venugopalan, et al.
Publicado: (2021)

Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
por: Lin, Bin, et al.
Publicado: (2022)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
por: Maguigan, Kelly L., et al.
Publicado: (2021)

Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
por: Long, Richard, et al.
Publicado: (2015)

A possible interaction between linezolid and digoxin: A case report of therapeutic drug monitoring
por: Yulin, Zhu, et al.
Publicado: (2020)

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion
por: Venugopalan, Veena, et al.
Publicado: (2018)

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection
por: Al-Shaer, Mohammad H., et al.
Publicado: (2019)

Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?—Experience from a prospective observational study
por: Fang, Jie, et al.
Publicado: (2020)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Determining therapeutic trough ranges for linezolid
por: Alsultan, Abdullah
Publicado: (2019)

Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure
por: Wills, Kenneth H., et al.
Publicado: (2021)

Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
por: Nakamura, Yoshihiko, et al.
Publicado: (2015)

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
por: Heysell, Scott K., et al.
Publicado: (2015)

Linezolid for drug‐resistant pulmonary tuberculosis
por: Singh, Bhagteshwar, et al.
Publicado: (2019)

Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019
por: Timmermans, Michaël, et al.
Publicado: (2021)

Acute interstitial nephritis and drug rash with secondary to Linezolid
por: Nayak, S., et al.
Publicado: (2012)

Linezolid dose adjustment according to therapeutic drug monitoring helps reach the goal concentration in severe patients, and the oldest seniors benefit more
por: Xu, Ying, et al.
Publicado: (2023)

1114. Effectiveness and Safety of Beta-lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection
por: Kunz Coyne, Ashlan J, et al.
Publicado: (2021)

Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections
por: Alffenaar, Jan-Willem, et al.
Publicado: (2021)

Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019)

Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series
por: Li, Meng Mei, et al.
Publicado: (2022)

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus
por: Alkabab, Y., et al.
Publicado: (2023)

Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients
por: Fang, Jie, et al.
Publicado: (2021)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
por: Alghamdi, Wael A., et al.
Publicado: (2019)

1548. Characterizing Cefepime Neurotoxicity: Experience from a Tertiary Care Center Performing β-lactam Therapeutic Drug Monitoring
por: Nys, Cara, et al.
Publicado: (2019)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Linezolid Resistance in Staphylococci
por: Stefani, Stefania, et al.
Publicado: (2010)

Linezolid-Associated Hypoglycemia
por: Johannesmeyer, Herman Joseph, et al.
Publicado: (2017)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia
por: Folan, Stephanie A, et al.
Publicado: (2018)

Simultaneous determination of linezolid, meropenem and theophylline in plasma
por: Attia, Ali K., et al.
Publicado: (2018)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

The Synergistic Activity of Rhamnolipid Combined with Linezolid against Linezolid-Resistant Enterococcus faecium
por: Chang, Qingru, et al.
Publicado: (2023)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Effect of a serum lactate monitoring recommendation policy on patients treated with linezolid
por: Im, Jae Hyoung, et al.
Publicado: (2021)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022)

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cssmtdtqiqujpkonsdlc8giahb